Abeona Therapeutics (ABEO) Research & Development (2016 - 2025)
Historic Research & Development for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $4.2 million.
- Abeona Therapeutics' Research & Development fell 5284.64% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year decrease of 1114.98%. This contributed to the annual value of $34.4 million for FY2024, which is 1051.43% up from last year.
- Per Abeona Therapeutics' latest filing, its Research & Development stood at $4.2 million for Q3 2025, which was down 5284.64% from $5.9 million recorded in Q2 2025.
- Abeona Therapeutics' Research & Development's 5-year high stood at $12.8 million during Q4 2021, with a 5-year trough of $4.2 million in Q3 2025.
- Moreover, its 5-year median value for Research & Development was $8.3 million (2021), whereas its average is $8.1 million.
- As far as peak fluctuations go, Abeona Therapeutics' Research & Development surged by 3967.92% in 2021, and later tumbled by 5284.64% in 2025.
- Quarter analysis of 5 years shows Abeona Therapeutics' Research & Development stood at $12.8 million in 2021, then tumbled by 51.01% to $6.3 million in 2022, then rose by 17.65% to $7.4 million in 2023, then grew by 21.89% to $9.0 million in 2024, then plummeted by 53.12% to $4.2 million in 2025.
- Its Research & Development was $4.2 million in Q3 2025, compared to $5.9 million in Q2 2025 and $9.9 million in Q1 2025.